Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions

Clinical trial NCT00652873 · COMPLETED

Trial details

NCT number: NCT00652873
Sponsor: Par Pharmaceutical, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

To Determine Bioequivalence Under Fed Conditions

Start date: 2001-07-01
Primary completion: 2001-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.